The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study
- PMID: 7500533
The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study
Abstract
Objective: To assess the long-term relationship of midlife blood pressure levels to late-life cognitive function.
Design: The 4678 surviving cohort members of the prospective Honolulu Heart Program (baseline, 1965-1968) were examined a fourth time in 1991 through 1993 and given a cognitive test.
Participants: The subjects were 3735 Japanese-American men living in Hawaii in the community or in institutions, with an average age of 78 years at the fourth examination.
Main outcome measures: Cognitive function, measured by the 100-point Cognitive Abilities Screening Instrument (CASI), was categorized into good (reference: a CASI score of 92 to 100), intermediate (< 92 to 82), and poor (< 82). Midlife systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were measured in 1965, 1968, and 1971. A respondent was classified into the following categories if two of three measurements fell into the following groups: for SBP, < 110, 110 to 139, 140 to 159, and > or = 160 mm Hg; and for DBP, < 80, 80 to 89, 90 to 94, and > or = 95 mm Hg.
Results: When we controlled for age and education, the risk for intermediate and poor cognitive function increased progressively with increasing level of midlife SBP category (P for trend < .03 and < .001, respectively). For every 10-mm Hg increase in SBP there was an increase in risk for intermediate cognitive function of 7% (95% confidence interval [CI], 3% to 11%) and for poor cognitive function of 9% (95% CI, 3% to 16%). Adjustment for prevalent stroke, coronary heart disease, and subclinical atherosclerosis reduced the strength of the relationship between midlife SBP and poor cognitive function to 5% (95% CI, 0% to 12%). The level of cognitive function was not associated with midlife DBP.
Conclusions: Midlife SBP is a significant predictor of reduced cognitive function in later life. Early control of SBP levels may reduce the risk for cognitive impairment in old age.
Similar articles
-
Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study.Stroke. 2001 Dec 1;32(12):2882-9. doi: 10.1161/hs1201.100392. Stroke. 2001. PMID: 11739991
-
Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study.Hypertension. 2010 Jun;55(6):1352-9. doi: 10.1161/HYPERTENSIONAHA.109.147389. Epub 2010 Apr 19. Hypertension. 2010. PMID: 20404223 Free PMC article.
-
Association of midlife blood pressure to late-life cognitive decline and brain morphology.Neurology. 1998 Oct;51(4):986-93. doi: 10.1212/wnl.51.4.986. Neurology. 1998. PMID: 9781518
-
The age-dependent relation of blood pressure to cognitive function and dementia.Lancet Neurol. 2005 Aug;4(8):487-99. doi: 10.1016/S1474-4422(05)70141-1. Lancet Neurol. 2005. PMID: 16033691 Review.
-
Hypertension and cognitive functioning among the elderly: an overview.Am J Ther. 2005 Jul-Aug;12(4):359-65. Am J Ther. 2005. PMID: 16041200 Review.
Cited by
-
Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.Psychol Aging. 2013 Mar;28(1):191-201. doi: 10.1037/a0031063. Psychol Aging. 2013. PMID: 23527743 Free PMC article.
-
What have observational studies taught us about brain health? An exploration of select cardiovascular risks and cognitive function.Cereb Circ Cogn Behav. 2024 Sep 2;7:100367. doi: 10.1016/j.cccb.2024.100367. eCollection 2024. Cereb Circ Cogn Behav. 2024. PMID: 39309313 Free PMC article.
-
Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: the Women's Health and Aging Study II.PLoS One. 2011;6(12):e27976. doi: 10.1371/journal.pone.0027976. Epub 2011 Dec 9. PLoS One. 2011. PMID: 22174760 Free PMC article.
-
Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.Neurodegener Dis Manag. 2012;2(2):183-195. doi: 10.2217/NMT.12.5. Neurodegener Dis Manag. 2012. PMID: 22798965 Free PMC article.
-
Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics.Neurol Clin. 2016 Nov;34(4):941-953. doi: 10.1016/j.ncl.2016.06.009. Epub 2016 Aug 4. Neurol Clin. 2016. PMID: 27720002 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical